News Archive

The search for PhD students for the ICEBIO research project has now been successfully completed. The second phase of the project, which is now starting, will focus on training the PhD students for upcoming sampling and laboratory experiments.

ICEBIO is a PhD network that will train the next generation of experts in glacier microbiology and biogeochemistry. ICEBIO will provide a database of the functional diversity and potential of the glacier biome, which will not only greatly improve our understanding of a threatened biome, but also demonstrate the potential for exploiting economic and ecological services.

Dr. Brill + Partner GmbH will, among other things, provide a risk assessment regarding pathogenic organisms from the glacier biome, including the inclusion of bacteria, fungi, and viruses.

Further Information: https://www.icebio.eu/pages/project/index.html

The ICEBIO Doctoral Network is supported by a grant from the European Commission’s MSCA Doctoral Network program under project number 101072761

Dr. Brill Genomics offers molecular biological techniques in the fields of hygiene, cosmetics, dermatology, pharmacy and food industry. For more information on sampling and DNA/RNA extraction, quantification of microorganisms, genes and viruses by quantitative polymerase chain reaction, microbiome and cosmetics, please watch the video here or visit this page: https://brillinstitutes.com/genomics

The General Meeting of the VUP elected a new Presidium today in Berlin. Dr. Florian H. H. Brill, Raimund Föhrenbacher, Dr. Emine Gökçe, Dr. Eckard Jantzen and Dr. Birgit Schumacher will lead the association in the next 2 years on a voluntary basis. Jutta Fink and Arthur Hofmann retired from the Executive Committee and were thanked very much.

From May 3rd - 5th 2023 the 33rd EWMA will take place in Milan. 

From our company, Dr. Florian H. H. Brill, Dr. Diana Mogrojevo and Vanessa Wiencke are co-authors on the presentation "ANTIMICROBIAL TESTING OF WOUND DRESSINGS USING A STANDARDIZED WOUND INFECTION MODEL" by Cornerlia Wiegand. 

The presentation will take place on 04.05.2023 from 17:30 - 17:38. Further information about EWMA can be found HERE

Dr. Brill has built up capacities for efficacy testing of antimicrobial products such as disinfectants, antiseptics, antiviral and antimicrobial surfaces etc.

We can offer the quickest turnaround times of 4 weeks for most test organisms and due to technical reasons 6 weeks for e.g. mycobacteria and SV40. We ensure a 48 h return service in case requests from eCAs are coming in and need to be addressed.

In case you need a guaranteed 3 week-service (or 6 weeks for slower replicating organisms/viruses) we add a 25 % fee onto the normal price but then you get the guarantee and we are running for you.

The highly experienced labs are at your service. Take a look inside:

Last year the prEN 17430 was published and the final norm is going in the formal vote now, it can be expected at the end of 2023. Of course the standard is established and accredited in our virucidal testing lab in Bremen. We offer a screening program for checking how your hand rubs with virucidal or limited virucidal spectrum activity are performing.

Until 31/10/2023 we offer the screening test with 15 % discount.

Take a look inside our laboratory:

Dr. Brill + Partner developed in a research project financed by the Hamburg health authorities and in cooperation with the Universitätsklinikum Hamburg-Eppendorf a phase 3 test model for surface disinfection procedures. The model includes clinical isolated organisms as well as practice-like surfaces from the hospital in the phase 3 step 1-test as well as the opportunity to perform field studies in the UKE. In addition, the application of the product was developed further meeting practical conditions.

The data will be presented on the DGKH-event on May 12 and 13 in Essen. The paper is in preparation but tests can be order with us as of now. In case you are interested please feel free to contact us.

Take a look inside our laboratory: 

image source: https://www.hamburg-news.hamburg/standort/uke-ergebnisse-der-weltweit-groessten-studie-zu-corona-folgen

In pharma industry production site that would like or need to change their hygiene regimen, the new established process has to be validated. Based on our phase 3-research project as well as existing standards such as EN 13697 and EN 16615 we can offer such validations with locally in the production site isolated test organisms and surface materials from the site.

Please contact us in case you are interested.

The validation of reprocessing procedures for reusable medical devices according to ISO 17664-1 and -2 under GLP for the US-market is an important hot topic and key for registration of medical devices with FDA. Of course we can use the recently published frame standard ANSI/AAMI ST98:2022 as a basis but also the German guidelines, such as ISO 15883-series.

We are ready to market in our bactericidal laboratory as of July 1st 2023 to offer these services under GLP and subsequently FDA compliant. The 10 % discount will be granted for all quotations accepted from now on until the end of 2023.

Take a look inside our laboratory:

The company CONSTELLATION Clean GmbH and the KEBOS Group are merging. This also affects our subsidiaries Dr.Brill + Kebos GmbH & Co. KG and Hygienic Solutions & Services are also affected.  You can find all information about the merger in the attached press release.

230404 Kebos Press Release Deutsch.pdf

Dr. Brill + Partner GmbH Institute for Hygiene and Microbiology. will be present at the 33rd ECCMID from the 15th-18th April 2023 in Copenhagen.
Our team will have a poster about the project: "BioRes Test: A standardized test to determine the development of resistance in microorganisms against biocides".

Here is a short summary:
Surface disinfectants and antimicrobial surfaces are important for hygiene and the protection of materials. However, bacteria can develop resistance to disinfectants and material-protection agents, increasing the risk of cross-resistance to antibiotics.
Disinfectants and antimicrobial material coatings are approved within the framework of the EU biocide regulation but there is currently a lack of standardized test methods that would provide industrial applicants and the assessing authorities with a framework for assessment.
The aim of this project is to develop a standardized test method to determine the potential for the development of resistance and cross-resistance when using surface disinfectants and antimicrobial surfaces. The focus is on the development of resistance through de novo mutations and the test procedures are developed on the basis of procedures previously published in scientific journals.

We are looking forward to exciting conversations!

From May 12 - 13, 2023 the Symposium for Hospital Hygiene of the DGKH will take place in Essen. 
We are also represented this year with some lectures at the symposium:

Friday, 12.05.2023 / 14:30 - 16:00

• Bakterielle Resistenzen und Toleranzen gegen Desinfektionsmittel und antimikrobielle Oberflächen F. Schreiber (Berlin), F. H.H. Brill (Hamburg), D. Mogrovejo (Hamburg), J. Klock (Hamburg), S. Schmidt (Berlin), C. Sündermann (Berlin), V. Boenke (Berlin), N. Nordholt (Berlin)

Saturday, 13.05.2023 / 11:00 - 12:30

• Phase 3-Wirksamkeitsprüfung für Flächendesinfektionsmittel – Feldstudie vs. Simulated-use-Test – wie kommen wir der Praxis näher? F. H. H. Brill (Hamburg), J. K. Knobloch (Hamburg)
• Sind klinische Isolate Multiresistenter Erreger stabiler als Laborstämme gegenüber Desinfektionsmitteln? Daten einer Hamburger Studie F. H. H. Brill (Hamburg)

The entire program and more information about event you can find HERE